Aarti Pharmalabs
Aarti Pharmalabs, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions. Founded in 1984, the company has established itself as a leader in the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates, catering to both domestic and international markets. With a diverse portfolio that includes specialty chemicals and formulations, Aarti Pharmalabs is recognised for its commitment to quality and innovation. The company’s state-of-the-art facilities and adherence to stringent regulatory standards set it apart in a competitive landscape. Notable achievements include significant expansions and collaborations that have bolstered its market position, making Aarti Pharmalabs a trusted name in the pharmaceutical sector.
DitchCarbon Score
How does Aarti Pharmalabs's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aarti Pharmalabs's score of 1 is lower than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Aarti Pharmalabs's reported carbon emissions
In 2023, Aarti Pharmalabs reported carbon emissions of approximately 37,390,000 kg CO2e for Scope 1 and about 79,746,000 kg CO2e for Scope 2. This represents a significant increase from 2022, where emissions were 37,390,000 kg CO2e for Scope 1 and 79,746,000 kg CO2e for Scope 2. The total emissions for 2024 further escalated to approximately 88,101,320 kg CO2e for Scope 1 and about 95,764,460 kg CO2e for Scope 2. Aarti Pharmalabs has committed to achieving net-zero emissions by 2050, with targets set across all scopes of emissions. The company is actively working towards these long-term goals, having initiated its commitment in 2023. The intensity of emissions per tonne of product was reported at 1,350 kg CO2e in 2022, indicating a focus on reducing carbon footprints in production processes. As a key player in the pharmaceuticals, biotechnology, and life sciences sector, Aarti Pharmalabs is aligning its operations with industry standards for climate action, demonstrating a proactive approach to sustainability and environmental responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 37,390,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 79,746,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Aarti Pharmalabs is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
